SE9500023L - Sätt att detektera cancer - Google Patents

Sätt att detektera cancer

Info

Publication number
SE9500023L
SE9500023L SE9500023A SE9500023A SE9500023L SE 9500023 L SE9500023 L SE 9500023L SE 9500023 A SE9500023 A SE 9500023A SE 9500023 A SE9500023 A SE 9500023A SE 9500023 L SE9500023 L SE 9500023L
Authority
SE
Sweden
Prior art keywords
amino
acid sequence
fusion proteins
polypeptides
homologues
Prior art date
Application number
SE9500023A
Other languages
Unknown language ( )
English (en)
Swedish (sv)
Other versions
SE9500023D0 (sv
Inventor
Lars Rydlander
Peter Bjoerklund
Original Assignee
Beki Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9401687A external-priority patent/SE9401687D0/xx
Application filed by Beki Ab filed Critical Beki Ab
Priority to SE9500023A priority Critical patent/SE9500023L/
Publication of SE9500023D0 publication Critical patent/SE9500023D0/xx
Priority to AU25821/95A priority patent/AU2582195A/en
Priority to EP95920334A priority patent/EP0765479A1/fr
Priority to JP7529563A priority patent/JPH10500408A/ja
Priority to PCT/SE1995/000532 priority patent/WO1995031728A1/fr
Publication of SE9500023L publication Critical patent/SE9500023L/

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4741—Keratin; Cytokeratin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
SE9500023A 1994-05-17 1995-01-04 Sätt att detektera cancer SE9500023L (sv)

Priority Applications (5)

Application Number Priority Date Filing Date Title
SE9500023A SE9500023L (sv) 1994-05-17 1995-01-04 Sätt att detektera cancer
AU25821/95A AU2582195A (en) 1994-05-17 1995-05-15 Method of detecting cancer involving fragments of cytokeratin 18 and corresponding antibodies
EP95920334A EP0765479A1 (fr) 1994-05-17 1995-05-15 Procede de detection du cancer a base de fragments de cytokeratine 18 et d'anticorps correspondants
JP7529563A JPH10500408A (ja) 1994-05-17 1995-05-15 サイトケラチン１８のフラグメントおよび対応する抗体を伴う癌の検出法
PCT/SE1995/000532 WO1995031728A1 (fr) 1994-05-17 1995-05-15 Procede de detection du cancer a base de fragments de cytokeratine 18 et d'anticorps correspondants

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9401687A SE9401687D0 (sv) 1994-05-17 1994-05-17 Method of detecting cancer
SE9500023A SE9500023L (sv) 1994-05-17 1995-01-04 Sätt att detektera cancer

Publications (2)

Publication Number Publication Date
SE9500023D0 SE9500023D0 (sv) 1995-01-04
SE9500023L true SE9500023L (sv) 1995-11-18

Family

ID=26662055

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9500023A SE9500023L (sv) 1994-05-17 1995-01-04 Sätt att detektera cancer

Country Status (5)

Country Link
EP (1) EP0765479A1 (fr)
JP (1) JPH10500408A (fr)
AU (1) AU2582195A (fr)
SE (1) SE9500023L (fr)
WO (1) WO1995031728A1 (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5670325A (en) * 1996-08-14 1997-09-23 Exact Laboratories, Inc. Method for the detection of clonal populations of transformed cells in a genomically heterogeneous cellular sample
DK0785274T3 (da) * 1996-01-18 2000-12-27 Aventis Pharma Gmbh Kunstigt rekombinant substrat (rAGG-1) og nativ aggrecan til undersøgelse af den proteolytiske aktivitet af "aggrecanase" i
US5741650A (en) * 1996-01-30 1998-04-21 Exact Laboratories, Inc. Methods for detecting colon cancer from stool samples
US6100029A (en) * 1996-08-14 2000-08-08 Exact Laboratories, Inc. Methods for the detection of chromosomal aberrations
US6146828A (en) * 1996-08-14 2000-11-14 Exact Laboratories, Inc. Methods for detecting differences in RNA expression levels and uses therefor
US6203993B1 (en) 1996-08-14 2001-03-20 Exact Science Corp. Methods for the detection of nucleic acids
US6300077B1 (en) 1996-08-14 2001-10-09 Exact Sciences Corporation Methods for the detection of nucleic acids
US5952178A (en) 1996-08-14 1999-09-14 Exact Laboratories Methods for disease diagnosis from stool samples
US6020137A (en) * 1996-08-14 2000-02-01 Exact Laboratories, Inc. Methods for the detection of loss of heterozygosity
US5928870A (en) * 1997-06-16 1999-07-27 Exact Laboratories, Inc. Methods for the detection of loss of heterozygosity
US6207380B1 (en) 1997-09-15 2001-03-27 Abbott Laboratories Reagents and methods useful for detecting diseases of the urinary tract
US7393529B2 (en) 1998-04-09 2008-07-01 Idexx Laboratories, Inc. Methods and compositions for inhibiting binding of IgE to a high affinity receptor
US6734287B1 (en) * 1998-04-09 2004-05-11 Idexx Laboratories, Inc. Specific binding proteins for treating canine allergy
US6280947B1 (en) 1999-08-11 2001-08-28 Exact Sciences Corporation Methods for detecting nucleotide insertion or deletion using primer extension
AU781805B2 (en) * 1999-08-13 2005-06-16 Brigham And Women's Hospital Inhibitors of the lectin complement pathway (LCP) and their use
WO2002055555A2 (fr) * 2000-12-21 2002-07-18 Genzyme Corp Composes antigeniques a base de proteine cytokeratine-18 (ck-18), pour la therapie et le diagnostic, et procedes d'utilisation correspondants
WO2003086456A2 (fr) * 2002-04-05 2003-10-23 Arius Research, Inc. Profilage antigenique de cellules neoplasiques, therapie oncogene faisant appel a des anticorps fonctionnels diriges contre lesdites cellules et complexes immuns cytotoxiques ainsi formes
WO2005074968A2 (fr) * 2004-02-10 2005-08-18 Universiteit Maastricht Utilisation medicale de peptides basiques
US9109256B2 (en) 2004-10-27 2015-08-18 Esoterix Genetic Laboratories, Llc Method for monitoring disease progression or recurrence
US9777314B2 (en) 2005-04-21 2017-10-03 Esoterix Genetic Laboratories, Llc Analysis of heterogeneous nucleic acid samples
EP3153860A3 (fr) * 2005-12-22 2017-06-14 Abbott Molecular Inc. Procédés et combinaisons de marqueurs pour dépister la prédisposition au cancer du poumon
US8524453B2 (en) 2006-02-10 2013-09-03 The Brigham And Woman's Hospital, Inc. Lectin complement pathway assays and related compositions and methods
US7883904B2 (en) 2006-05-19 2011-02-08 The Cleveland Clinic Foundation Detection and monitoring of liver damage

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0167616B1 (fr) * 1984-01-06 1995-07-26 The Regents Of The University Of California Marqueurs tumoraux de cytokeratine et analyses en vue de leur detection
DE3815932A1 (de) * 1988-01-26 1989-08-03 Progen Biotechnik Gmbh Verfahren zur identifizierung des ursprungs einer zellgewebsprobe
DE3923951A1 (de) * 1989-07-19 1991-01-31 Boehringer Mannheim Gmbh Verfahren zum nachweis von leberzirrhose

Also Published As

Publication number Publication date
JPH10500408A (ja) 1998-01-13
WO1995031728A1 (fr) 1995-11-23
AU2582195A (en) 1995-12-05
EP0765479A1 (fr) 1997-04-02
SE9500023D0 (sv) 1995-01-04

Similar Documents

Publication Publication Date Title
SE9500023L (sv) Sätt att detektera cancer
CO4870792A1 (es) Compuestos y conjunto de medios de diagnostico para detectar y vigilar la progresion de cancer de prostata
WO1998050554A3 (fr) POLYNUCLEOTIDES ET POLYPEPTIDES D'$i(ENTEROCOCCUS FAECALIS)
WO1998053076A3 (fr) Composes permettant de diagnostiquer la tuberculose et leurs procedes d'utilisation
MX9801687A (es) Compuestos y metodos para el diagnostico de tuberculosis.
CA2131826A1 (fr) Gene mn et proteine
EP2060630A3 (fr) PCA3, gènes de PCA3, et procédés d'utilisation
EP1006182A3 (fr) Fragments polypeptidiques du facteur VIIIc, sondes et séquences de ADN correspondants et constructions de ADN
DE69638162D1 (de) Bindegewebs wachstumsfaktor (ctgf)
WO1998016645A3 (fr) Composes et procedes pour diagnostiquer la tuberculose
CA2272845A1 (fr) Matiere virale et fragments de nucleotides associes a la sclerose en plaques, utilises a des fins diagnostiques, prophylactiques, et therapeutiques
EP1985705A3 (fr) Séquences de nucléotide de souches de pestivirus, polypeptides codées par ces séquences et utilisation correspondante pour le diagnostic et la prévention d'infections de pestivirus
WO1999047639A3 (fr) GENES ET POLYPEPTIDES DU $i(STAPHYLOCCOCUS AUREUS)
EA200000845A1 (ru) Ген, кодирующий новый маркер рака
DE69716305T2 (de) Peptidereagenz zum nachweis von humanem cytomegalovirus (cmv)
ATE433463T1 (de) Monospezifische antikörper gegen fibrinogen und fibrinopeptide b
Heck et al. Isolation, characterization, and amino-terminal amino acid sequence analysis of human neutrophil cathepsin G from normal donors
DK0535150T3 (da) Humant makrofag-inflammatorisk protein-2-beta
CA2195385A1 (fr) Substrat recombinant artificiel (ragg1) et aggrecan native pour etudier l'activite proteolytique de l'aggrecanase dans les systemes de culture cellulaire
ATE304549T1 (de) Menschliches netrin-1
CA2174212A1 (fr) Test pour detecter la fixation du virus de l'hepatite c a ses recepteurs
FR2722508B1 (fr) Cassette d'expression d'une proteine p30 de toxoplasma gondii
ATE407944T1 (de) Mit trp-proteinen verwandtes protein mtr1 und dieses codierende dna-sequenz
WO2001065262A3 (fr) Reactifs et methodes de detection des pathologies mammaires
Burridge et al. The application of labeled lectins and antibodies to SDS gels and their use in studying glycoproteins and cell surface antigens during development

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 9500023-8

Format of ref document f/p: F